Episealer® presentations at several clinical congresses
Episurf Medical (Nasdaq: EPIS B) today announces that the company’s knee and ankle technologies, Episealer® Knee and Talus, recently have been presented at several clinical congresses, as part of the scientific program or through surgeon-led initiatives.
At the 29th International Congress of SLAOT (Sociedad Latinoamericana de Ortopedia y Traumatología) in San José, Costa Rica (September 20-22), Dr Christian Kothny gave a presentation on the Episealer® implant technologies, focusing on clinical indications, surgical techniques, and clinical results. At the XL Orthopedic Days, organised by the Polish Society of Orthopaedics and Traumatology (Poznań, Poland, September 22-23), Prof. Łukasz Łapaj gave a presentation where similar topics were covered. At the 17th World Congress of ICRS (International Cartilage Regeneration & Joint Preservation Society, Barcelona, Spain, September 9-12), the Episealer® implant systems were included in presentations by Dr Francesca de Caro and Priv.-Doz. Dr. med. Philip Rößler.
“We are pleased to see that surgeons globally are directing their attention to the Episealer® technology at an increasing pace. Our initially targeted patient population has always been an important discussion topic at clinical congresses, given the treatment challenges. Our results show that surgeons have an expanded toolbox to treat these patients. Combined with the efficient surgical technique and pre-surgical planning, the Episealer® represents an attractive option for surgeons, and we believe that the technology is starting to receive the attention it deserves”, says Pål Ryfors, CEO Episurf Medical.
